ArQule Inc: Premium Company Profile

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Databook
Pages	47
ISBN Number	not applicable
Product Code	DAT09407

Price

£265.00
approximately: $468 | €336

PRINT £265 ($468 | €336)

Order above formats by FAX

Summary

Introduction

ArQule, founded as a chemistry service company, became a drug discovery and development company by acquiring Cyclic Pharmaceuticals in 2003. The company's proprietary drug discovery platforms such as Cancer Survival Pathways and Activated Checkpoint Therapy have helped it building a product pipeline.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. It's product pipeline includes: ARQ 501 in Phase II for sarcoma, head and neck cancer and pancreatic cancer; ARQ 171 in Phase I for cancer; and ARQ 197 in Phase II for the treatment of solid tumors and pancreatic cancer.

The company recognizes revenues in the form of collaboration fees and milestone payments from the companies with which it has entered into collaboration agreements with Roche and Wyeth.

The company's total revenues increased during 2004-2006, from $5 million to $6.6 million. The company's only contributor to revenue growth during 2004-2006 was revenues received under license and collaboration agreements with Roche and Wyeth.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: ArQule - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 1: ArQule - Key Facts
- Table 2: ArQule - Locations and Subsidiaries
- Table 3: ArQule - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: ArQule - Key Events Impacting Share Price Performance
- Table 5: ArQule - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: ArQule - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: ArQule - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: ArQule - Cash Flow, 2002-2006 ($ Mn)
- Table 9: ArQule - Revenue Breakdown by Division, 2002-2006 ($ Mn)
- Table 10: ArQule - in -House Products
- Table 11: ArQule - Collaboration Products
- Table 12: ArQule - Forecast Sales, 2006-2010 ($ Mn)
- Table 13: ArQule - Key Competitors
- Table 14: ArQule - Key Clients
- Table 15: ArQule - Key Shareholders
- Table 16: ArQule - SWOT Analysis Summary
- Table 17: ArQule - Value Chain Analysis
- Table 18: ArQule - Scorecard
- Table 19: ArQule - Key Employees
- Table 20: ArQule - Financial and Operational Overview